Daily magazine about Latvia www.latviannews.lv
Patience is the art of hoping.
Luc de Clapiers de Vauvenargues
Russian version

"Grindeks" turnover up 5% in January-February

RIGA, April 3 - Pharmaceutical company "Grindeks", in accordance with the Group's annual budget and plan for 2013, achieved a 5 percent increase in turnover in the first two months of 2013, "Nozare.lv" was informed by the company.

As reported, "Grindeks" plans to achieve approximately LVL 100 million in turnover and LVL 12 million in profit this year.

"Grindeks" Group turned over LVL 82.7 million in 2012, LVL 13.1 million or 18.8 percent more than in 2011. The Group's net profit related to its shareholders amounted to LVL 9.6 million, LVL 2.9 million or 43.3 percent more than in 2012, according to "Grindeks" unaudited consolidated financial statements submitted to the "NASDAQ OMX Riga" stock exchange.

"Grindeks" specializes in the heart and cardiovascular, CNS and anti-cancer medication therapeutic groups, but the company also expands its production in other product groups. The registration of antimicrobial and other medications has been started in several CIS countries.

"Grindeks" informs that it continually assesses export opportunities on new markets. Currently, talks are underway with potential cooperation partners for export to Southeast Asia.

Before the comment please read the rules of use our webpage.. Thank you.